In the latest trading session,, 0.9 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.87. With the company’s most recent per share price at $0.86 changing hands around $0.07 or 8.80% at last look, the market valuation stands at $14.57M. PSTV’s current price is a discount, trading about -210.47% off its 52-week high of $2.67. The share price had its 52-week low at $0.24, which suggests the last value was 72.09% up since then. When we look at Plus Therapeutics Inc’s average trading volume, we note the 10-day average is 5.88 million shares, with the 3-month average coming to 16.57 million.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV is in green as seen in intraday trades today. With action 33.73%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -25.46%, with the 5-day performance at 33.73% in the green. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is -43.61% down. Looking at the short shares, we see there were 1.13 million shares sold at short interest cover period of 0.05 days.
Plus Therapeutics Inc (PSTV) estimates and forecasts
Year-over-year growth is forecast to reach -16.51% down from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 1.11M. 4 analysts are of the opinion that Plus Therapeutics Inc’s revenue for the current quarter will be 1.14M. The company’s revenue for the corresponding quarters a year ago was 1.68M and 1.28M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -33.66%. The estimates for the next quarter sales put growth at -11.06%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.51%. The 2025 estimates are for Plus Therapeutics Inc earnings to increase by 57.69%, but the outlook for the next 5-year period is at 49.80% per year.
PSTV Dividends
Plus Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-26.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.07% of Plus Therapeutics Inc shares while 11.43% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.17%.
Among Mutual Funds, the top two as of Jan 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 34.43 shares estimated at $29333.0 under it, the former controlled 0.20% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.19% of the shares, roughly 32.54 shares worth around $27721.0.
